Sundaram-Clayton (SUNCLAY) Q2 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 26/27 earnings summary
4 Nov, 2026Executive summary
Standalone Q2 FY27 total income was ₹631.9 crore and PAT ₹39.5 crore; H1 income rose 28% YoY to ₹1,159.8 crore and PAT rose 52% to ₹56.5 crore.
Consolidated results remained loss-making: Q2 loss attributable to owners was ₹50.8 crore and H1 loss was ₹110.1 crore.
Financial highlights
Standalone Q2 revenue from operations was ₹629.4 crore vs ₹458.6 crore YoY; PAT was ₹39.5 crore vs ₹20.2 crore.
Standalone H1 revenue from operations was ₹1,153.6 crore vs ₹900.7 crore; PAT was ₹56.5 crore vs ₹37.2 crore.
Consolidated Q2 revenue from operations was ₹697.7 crore vs ₹494.8 crore; H1 revenue was ₹1,289.4 crore vs ₹1,006.4 crore.
Standalone Q2 EBITDA was ₹98.9 crore, with a 15.7% margin, vs ₹79.1 crore and 17.1% a year earlier.
Outlook and guidance
Management is targeting a financial turnaround in US operations through restructuring and improved production and operating metrics, with focus on sales growth, cost competitiveness and execution.
Production across manufacturing facilities increased in Q2 in line with customer requirements; US production ramp-up supported manufacturing and customer deliveries.
Latest events from Sundaram-Clayton
- Consolidated losses widened due to overseas subsidiaries despite stable standalone performance.SUNCLAY
Q1 24/25 - Standalone profit improved, but consolidated loss persisted due to overseas operations and high debt.SUNCLAY
Q2 24/25 - Standalone profit and consolidated loss reported for Q3 FY25; leverage remains elevated.SUNCLAY
Q3 24/25 - EBITDA and PAT improved in FY25, driven by new facility launch and operational consolidation.SUNCLAY
Q4 24/25 - EBITDA up 16% and US sales hit record, despite revenue dip from Hosur business sale.SUNCLAY
Q1 25/26 - EBITDA rose 9% year-over-year in Q2 FY2025-26, with strong operational and ESG performance.SUNCLAY
Q2 25/26 - EBITDA margin improved to 19.7% in Q3 FY26, with higher standalone profit and operational gains.SUNCLAY
Q3 25/26 - EBITDA margins rose and operational resilience strengthened, despite lower revenue from divestment.SUNCLAY
Q4 25/26 - Standalone revenue up 19% YoY, but margins pressured by rising input costs.SUNCLAY
Q1 26/27